Bokf Na Reduces Stock Position in Bristol Myers Squibb Company $BMY

robot
Abstract generation in progress

Bokf Na has reduced its stake in Bristol Myers Squibb Company by 10.6% in the fourth quarter, selling 27,973 shares and now owning 236,607 shares valued at $12.763 million. Despite Bokf Na’s reduction, several other institutional investors increased their positions in the biopharmaceutical company during the same period. Bristol Myers Squibb recently reported strong Q1 earnings, beating analyst estimates, and declared a quarterly dividend, while facing mixed sentiment from recent news and analyst ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin